Deccan Hematolink 3.0: Yashoda Hospitals hosts global meet on blood cancer
Yashoda Hospitals–Hitech City organised ‘Deccan Hematolink 3.0’, an international conference on Artificial Intelligence in Hematology, drawing over 700 national and 10 international experts.
Hyderabad: Yashoda Hospitals-Hitech City hosted ‘Deccan Hematolink 3.0’, the largest international conference on Artificial Intelligence (AI) in the field of Hematology with over 700 national and 10 international oncology and hemato-oncology medical experts participating.
Yashoda Group Hospitals Managing Director, Dr.G.S.Rao, who inaugurated the two-day conference, said fighting blood cancer is not just about medical treatment, it also requires mental strength, financial support and community awareness. Cancer burden in India is steadily rising, projected to increase from 1.46 million new cases (2022) to 1.57 million (2025), and blood cancers remain a significant and growing part of clinical practice.
Until recently, many blood cancer patients had limited treatment options. However, the advances now available in cancer treatment from bone marrow transplants to cutting-edge immunotherapies like CAR-T cell therapy are revolutionising cancer treatment, offering new hope to cancer patients, said Dr. Rao.
Yashoda Hospitals-Hitech City, Senior Hematologist, Dr. Ganesh Jaishetwar, said Yashoda Hospitals, in the last 13 years, has performed more than 600 successful bone marrow transplants and treated thousands of blood cancer patients, giving them a new lease of life.
